NATUPHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 29805601
Sorøvej 26, 4291 Ruds Vedby
info@natupharma.dk
tel: 58544295
www.natupharma.co.uk
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 12 951.86 | 13 057.30 | 8 994.50 | 10 152.60 | 10 041.07 |
| Employee benefit expenses | -5 737.34 | -6 636.57 | -6 619.31 | -6 279.85 | -7 154.76 |
| Other operating expenses | - 164.67 | ||||
| Total depreciation | - 553.01 | - 536.13 | - 686.26 | - 890.13 | -1 160.26 |
| EBIT | 6 661.51 | 5 884.59 | 1 688.92 | 2 982.63 | 1 561.38 |
| Other financial income | 319.48 | 103.99 | 254.22 | 239.34 | 63.11 |
| Other financial expenses | - 727.27 | - 657.68 | -1 249.61 | - 859.53 | - 935.72 |
| Net income from associates (fin.) | 1 137.72 | 1 314.47 | 1 599.82 | 1 747.44 | 2 933.17 |
| Pre-tax profit | 7 391.43 | 6 645.36 | 2 293.36 | 4 109.88 | 3 621.93 |
| Income taxes | -1 410.52 | -1 187.24 | - 141.95 | - 529.62 | - 143.01 |
| Net earnings | 5 980.91 | 5 458.13 | 2 151.42 | 3 580.25 | 3 478.93 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 104.98 | 235.96 | 326.48 | 302.57 | |
| Goodwill | 1 416.74 | 1 180.62 | 944.50 | 708.37 | 472.25 |
| Intangible assets total | 1 416.74 | 1 285.60 | 1 180.46 | 1 034.85 | 774.82 |
| Buildings | 522.94 | 409.72 | 299.60 | 210.03 | 2 951.95 |
| Machinery and equipment | 2 377.04 | 2 207.19 | 3 729.98 | 3 420.40 | 3 155.62 |
| Advance payments and construction in progress | 889.18 | ||||
| Tangible assets total | 2 899.98 | 3 506.08 | 4 029.58 | 3 630.43 | 6 107.57 |
| Holdings in group member companies | 10 609.64 | 11 244.03 | 13 061.74 | 13 683.62 | 15 022.22 |
| Other receivables | 56.25 | 56.25 | 56.25 | 279.38 | 223.13 |
| Investments total | 10 665.89 | 11 300.28 | 13 117.98 | 13 962.99 | 15 245.34 |
| Long term receivables total | |||||
| Raw materials and consumables | 3 645.30 | 4 631.01 | |||
| Finished products/goods | 4 476.21 | 5 576.39 | 5 610.60 | 3 336.13 | 4 394.90 |
| Inventories total | 4 476.21 | 5 576.39 | 5 610.60 | 6 981.43 | 9 025.92 |
| Current trade debtors | 17 256.54 | 16 537.37 | 15 522.65 | 16 660.23 | 20 093.01 |
| Current amounts owed by group member comp. | 6 967.40 | 5 489.70 | 6 853.99 | 8 208.51 | |
| Prepayments and accrued income | 195.69 | 9.25 | 30.00 | 189.50 | 22.50 |
| Current other receivables | 93.44 | 16.90 | 2.37 | 2.38 | 26.62 |
| Short term receivables total | 24 513.08 | 22 053.21 | 22 409.02 | 25 060.61 | 20 142.13 |
| Cash and bank deposits | 1.96 | 29.54 | 1.62 | 4.50 | 0.69 |
| Cash and cash equivalents | 1.96 | 29.54 | 1.62 | 4.50 | 0.69 |
| Balance sheet total (assets) | 43 973.86 | 43 751.10 | 46 349.25 | 50 674.82 | 51 296.48 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 2 000.00 | 2 000.00 | 2 000.00 | 2 000.00 | 2 000.00 |
| Shares repurchased | 2 500.00 | 13 377.81 | |||
| Other reserves | 2 335.59 | 81.88 | 1 783.87 | 3 601.91 | - 213.92 |
| Retained earnings | 5 732.86 | 13 587.06 | 16 535.98 | 16 932.52 | 3 964.52 |
| Profit of the financial year | 5 980.91 | 5 458.13 | 2 151.42 | 3 580.25 | 3 478.93 |
| Shareholders equity total | 18 549.36 | 21 127.07 | 22 471.26 | 26 114.68 | 22 607.33 |
| Provisions | 742.71 | 704.11 | 730.53 | 690.64 | 666.50 |
| Non-current loans from credit institutions | 3 002.05 | 1 756.20 | 511.55 | 385.09 | 2 683.00 |
| Non-current other liabilities | 451.90 | 458.68 | |||
| Non-current deferred tax liabilities | 445.66 | 461.26 | 457.56 | ||
| Non-current liabilities total | 3 453.95 | 2 214.88 | 957.22 | 846.35 | 3 140.56 |
| Current loans from credit institutions | 3 106.17 | 5 251.10 | 9 834.26 | 11 581.02 | 9 355.79 |
| Current trade creditors | 5 204.51 | 7 150.45 | 8 265.82 | 9 109.16 | 5 042.10 |
| Current owed to group member | 4 893.22 | 3 920.55 | 1 672.71 | 8 267.09 | |
| Short-term deferred tax liabilities | 1 507.05 | 120.61 | 613.37 | 167.15 | |
| Other non-interest bearing current liabilities | 6 516.90 | 3 382.94 | 1 606.12 | 1 719.60 | 2 049.96 |
| Accruals and deferred income | 690.72 | ||||
| Current liabilities total | 21 227.84 | 19 705.04 | 22 190.24 | 23 023.15 | 24 882.09 |
| Balance sheet total (liabilities) | 43 973.86 | 43 751.10 | 46 349.25 | 50 674.82 | 51 296.48 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.